Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19

Five year trend study shows rebound in inappropriate use after an early pandemic dip, and a need to tackle overuse in all patients during viral illness outbreaks

12:45 AM

Author | Kara Gavin

Pill capsule pushing through a paper with amoxicillin printed on it.
Credit: Getty Images

America is going the wrong way when it comes to prescribing antibiotics, with 1 in 4 prescriptions going to patients who have conditions that the drugs won’t touch, a new study finds. 

In fact, the percentage of all antibiotic prescriptions given to treat conditions they’re useless against was even higher in December 2021 than it was before the pandemic began, the study shows.

And that means more chances for disease causing bacteria to evolve in ways that could make antibiotics useless for the patients who truly need them.

The percentage of people getting antibiotics for inappropriate reasons actually decreased a bit in the early months of the pandemic, when far fewer people sought medical care for infectious or non-infectious reasons, the new research shows. But it got back on the wrong track soon after. 

The study, published in the journal Clinical Infectious Diseases by a team from the University of Michigan, Northwestern University and Boston Medical Center, is based on data from more than 37.5 million children and adults covered by private insurance or Medicare Advantage plans from 2017 to 2021. Patients received antibiotic prescriptions from both in person and telehealth visits.

The team looked back at any new diagnosis given to each patient on the day they received a prescribed antibiotic, or in the three days prior to getting the prescription. If none of these diagnoses justified the use of antibiotics, they classified the prescription as inappropriate.

“Our study shows that the decline in exposure to inappropriate antibiotic prescriptions during the pandemic was only temporary,” says lead author Kao-Ping Chua, M.D., Ph.D., a pediatrician and health care researcher in the Department of Pediatrics at the U-M Medical School.

 “Our findings highlight the continued importance of quality improvement initiatives focused on preventing unnecessary antibiotic prescribing and antimicrobial resistance, which kills 48,000 Americans per year.”

Chua is a member of the Susan B. Meister Child Health Evaluation and Research center, and the U-M Institute for Healthcare Policy and Innovation, and has a joint appointment in the U-M School of Public Health.

Our findings highlight the continued importance of quality improvement initiatives focused on preventing unnecessary antibiotic prescribing and antimicrobial resistance."

--Kao-Ping Chua, M.D., Ph.D.

Key findings:

  • In all, 60.6 million antibiotic prescriptions were dispensed to patients nationwide in the five years of the study period from January 2017 to December 2021. The share of these prescriptions that went to people with conditions for which antibiotics are inappropriate rose from 25.5% to 27.1% of all antibiotics dispensed during this period.
  • The proportion of all patients who got antibiotics for inappropriate reasons was 1.7% in December 2019. It dipped to 0.9% of all patients in April 2020 – largely because fewer people got antibiotics in general – and returned to 1.7% of all patients by December 2021.
  • Some groups of people were more likely to receive inappropriate antibiotics. At the end of 2021, 30% of antibiotics for older adults with Medicare Advantage coverage were inappropriate, compared with 26% of antibiotics for adults with private health insurance and 17% of antibiotics for children with private insurance.
  • Among the diagnoses listed for people who received antibiotics for inappropriate reasons, “contact with and suspected exposure to COVID-19” was one of the top two most common reasons from March 2020 through December 2021. There is no evidence that taking antibiotics after an exposure can reduce risk of developing COVID-19. 
  • Of all the inappropriately prescribed antibiotics dispensed in the last half of 2021, 15% were for a COVID-19 infection. And COVID-19 infections accounted for 2% of all antibiotic prescribing – regardless of appropriateness -- from March 2020 through December 2021.
  • Telehealth appointments accounted for 9% of all inappropriate antibiotic prescriptions in the latter half of 2021, down somewhat from 2020. There were almost no telehealth-based antibiotic prescriptions before March 2020.
  • For 28% to 32% of the antibiotic prescriptions filled by patients in the study period, there was no diagnosis available to judge appropriateness, potentially because the patient received the prescription at an appointment that didn’t get billed to their insurance, or it was a refill of a past prescription. The percentage was especially high in the first months of the pandemic.
  • 45% of all the patients in the study received antibiotics at least once in the five years, and 13% received them four or more times. 

    SEE ALSO: Nearly a Quarter of Antibiotic Prescriptions May Be Unnecessary

Additional authors: In addition to Chua, the study’s authors are Michael Fischer, M.D., M.S. of the Boston Medical Center, statistician Moshiur Rahman, Ph.D. of CHEAR, and Jeffrey Linder, M.D., M.P.H. of Northwestern University. 

Citation: Changes in the Appropriateness of U.S. Outpatient Antibiotic Prescribing after the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data, Clinical Infectious Diseases, DOI:10.1093/cid/ciae135

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.

 


More Articles About:

Health Care Delivery, Policy and Economics Covid-19 Pharmacy Medication Guidelines infectious disease Children's Health Primary Care Patient Safety
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Related

yellow background with hand in orange with invisible pills falling out of pill bottle
Health Lab

Antibiotic prescriptions for kids plummet during pandemic

Study finds declines in prescription drugs dispensed to children during COVID-19, including infection-related medicines and some used for chronic diseases.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Michigan Medicine Presents in spotlights on blue background
Michigan Medicine Presents

Michigan Medicine Presents: Tommy Wang, M.D., Dean, University of Michigan Medical School

Join MD student Cassie Evans and PhD student Sam Collie for a wide-ranging conversation with Dean Tommy Wang, M.D. As he reflects on his journey to medicine and academic leadership, Dr. Wang shares his perspectives on student well-being, artificial intelligence, education, research and patient care through the lens of his new role as dean of the University of Michigan Medical School.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

Medicare's New GLP-1 Bridge Program

An obesity expert welcomes new Medicare option for access to effective weight loss medication, and shares the new program’s limitations.
person holding scale with scrubs on and stethoscope
Health Lab

7 things to know about Medicare’s new GLP-1 coverage

Medicare coverage of GLP-1 drugs for weight loss including Wegovy and Zepbound has begun but has limits.
A person wears a protype infant sling on the front of their body. The sling has a special window to allow light to reach the baby.
Health Lab

Medical student’s invention aims to help infants with jaundice

University of Michigan medical student Daniel John has created BiliRoo, a low-cost, non-electric device designed to treat jaundice in newborns
baby with hearing aid on ear looking from side view with blue pacifier in mouth
Health Lab

Research may help better predict outcomes in kids with congenital cytomegalovirus

Two new studies may help researchers and clinicians better understand congenital cytomegalovirus (CMV), the most common infectious cause of birth defects and a leading cause of non-genetic hearing loss in children.
family smiling inside capitol
Health Lab

12-year-old shares journey with sickle cell anemia on Capitol Hill

A 12-year-old takes his story to Washington, D.C., sharing with lawmakers how specialized treatment transformed his life with sickle cell disease.